Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
29.7M
-
Shares change
-
-1.44M
-
Total reported value, excl. options
-
$64.9M
-
Value change
-
-$3.25M
-
Put/Call ratio
-
0.84
-
Number of buys
-
13
-
Number of sells
-
-33
-
Price
-
$2.19
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q3 2021
64 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q3 2021.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.7M shares
.
Largest 10 shareholders include BVF INC/IL (9.54M shares), NEA Management Company, LLC (9.09M shares), VANGUARD GROUP INC (2.26M shares), ACADIAN ASSET MANAGEMENT LLC (1.89M shares), DIMENSIONAL FUND ADVISORS LP (905K shares), BlackRock Inc. (875K shares), TWO SIGMA ADVISERS, LP (621K shares), RENAISSANCE TECHNOLOGIES LLC (596K shares), TWO SIGMA INVESTMENTS, LP (499K shares), and MILLENNIUM MANAGEMENT LLC (448K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.